FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3128782885> ?p ?o ?g. }

• W3128782885 abstract "Abstract Background Multipotent mesenchymal stromal cells (MSCs) are potentially therapeutic for muscle disease because they can accumulate at the sites of injury and act as immunosuppressants. MSCs are attractive candidates for cell-based strategies that target diseases with chronic inflammation, such as Duchenne muscular disease (DMD). We focused on the anti-inflammatory properties of IL-10 and hypothesized that IL-10 could increase the typically low survival of MSCs by exerting a paracrine effect after transplantation. Methods We developed a continuous IL-10 expression system of MSCs using an adeno-associated virus (AAV) vector. To investigate the potential benefits of IL-10 expressing AAV vector-transduced MSCs (IL-10-MSCs), we examined the cell survival rates in the skeletal muscles after intramuscular injection into mice and dogs. Systemic treatment with IL-10-MSCs derived from dental pulp (DPSCs) was comprehensively analyzed using the canine X-linked muscular dystrophy model in Japan (CXMD J ), which has a severe phenotype similar to that of DMD patients. Results In vivo bioluminescence imaging analysis revealed higher retention of IL-10-MSCs injected into the hindlimb muscle of mice. In the muscles of dogs, myofiber-like tissue was formed after the stable engraftment of IL-10-MSCs. Repeated systemic administration of IL-10-DPSCs into the CXMD J model resulted in long-term engraftment of cells and slightly increased the serum levels of IL-10. IL-10-hDPSCs showed significantly reduced expression of pro-inflammatory MCP-1 and upregulation of stromal-derived factor-1 (SDF-1). MRI and histopathology of the hDPSC-treated CXMD J indicated the regulation of inflammation in the muscles, but not myogenic differentiation from treated cells. hDPSC-treated CXMD J showed improved running capability and recovery in tetanic force with concomitant increase in physical activity. Serum creatine kinase levels, which increased immediately after exercise, were suppressed in IL-10-hDPSC-treated CXMD J . Conclusions In case of local injection, IL-10-MSCs could maintain the long-term engraftment status and facilitate associated tissue repair. In case of repeated systemic administration, IL-10-MSCs facilitated the long-term retention of the cells in the skeletal muscle and also protected muscles from physical damage-induced injury, which improved muscle dysfunction in DMD. We can conclude that the local and systemic administration of IL-10-producing MSCs offers potential benefits for DMD therapy through the beneficial paracrine effects of IL-10 involving SDF-1." @default.
• W3128782885 created "2021-02-15" @default.
• W3128782885 creator A5038008307 @default.
• W3128782885 creator A5045981942 @default.
• W3128782885 creator A5060434465 @default.
• W3128782885 creator A5064919780 @default.
• W3128782885 creator A5074650312 @default.
• W3128782885 creator A5082934985 @default.
• W3128782885 date "2021-02-04" @default.
• W3128782885 modified "2023-10-15" @default.
• W3128782885 title "Enhanced cell survival and therapeutic benefits of IL-10-expressing multipotent mesenchymal stromal cells for muscular dystrophy" @default.
• W3128782885 cites W1967223729 @default.
• W3128782885 cites W1970892084 @default.
• W3128782885 cites W1979497719 @default.
• W3128782885 cites W1993177677 @default.
• W3128782885 cites W1999139590 @default.
• W3128782885 cites W2014482299 @default.
• W3128782885 cites W2014673628 @default.
• W3128782885 cites W2018396053 @default.
• W3128782885 cites W2019713216 @default.
• W3128782885 cites W2052502677 @default.
• W3128782885 cites W2059066863 @default.
• W3128782885 cites W2067828733 @default.
• W3128782885 cites W2068135722 @default.
• W3128782885 cites W2073104176 @default.
• W3128782885 cites W2079047356 @default.
• W3128782885 cites W2084304128 @default.
• W3128782885 cites W2084954204 @default.
• W3128782885 cites W2085986454 @default.
• W3128782885 cites W2086344503 @default.
• W3128782885 cites W2086503927 @default.
• W3128782885 cites W2088500471 @default.
• W3128782885 cites W2095666785 @default.
• W3128782885 cites W2106117542 @default.
• W3128782885 cites W2113103868 @default.
• W3128782885 cites W2117938257 @default.
• W3128782885 cites W2123753106 @default.
• W3128782885 cites W2126134953 @default.
• W3128782885 cites W2134614924 @default.
• W3128782885 cites W2143379207 @default.
• W3128782885 cites W2157455235 @default.
• W3128782885 cites W2430686599 @default.
• W3128782885 cites W2518934106 @default.
• W3128782885 cites W2704163919 @default.
• W3128782885 cites W2765859637 @default.
• W3128782885 cites W2893714750 @default.
• W3128782885 cites W2904957593 @default.
• W3128782885 cites W2913950304 @default.
• W3128782885 cites W2996799736 @default.
• W3128782885 cites W2997167165 @default.
• W3128782885 cites W3045413372 @default.
• W3128782885 cites W4292330637 @default.
• W3128782885 doi "https://doi.org/10.1186/s13287-021-02168-1" @default.
• W3128782885 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7860619" @default.
• W3128782885 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33541428" @default.
• W3128782885 hasPublicationYear "2021" @default.
• W3128782885 type Work @default.
• W3128782885 sameAs 3128782885 @default.
• W3128782885 citedByCount "14" @default.
• W3128782885 countsByYear W31287828852021 @default.
• W3128782885 countsByYear W31287828852022 @default.
• W3128782885 countsByYear W31287828852023 @default.
• W3128782885 crossrefType "journal-article" @default.
• W3128782885 hasAuthorship W3128782885A5038008307 @default.
• W3128782885 hasAuthorship W3128782885A5045981942 @default.
• W3128782885 hasAuthorship W3128782885A5060434465 @default.
• W3128782885 hasAuthorship W3128782885A5064919780 @default.
• W3128782885 hasAuthorship W3128782885A5074650312 @default.
• W3128782885 hasAuthorship W3128782885A5082934985 @default.
• W3128782885 hasBestOaLocation W31287828851 @default.
• W3128782885 hasConcept C111335760 @default.
• W3128782885 hasConcept C126322002 @default.
• W3128782885 hasConcept C142724271 @default.
• W3128782885 hasConcept C161997846 @default.
• W3128782885 hasConcept C16930146 @default.
• W3128782885 hasConcept C170493617 @default.
• W3128782885 hasConcept C198826908 @default.
• W3128782885 hasConcept C203014093 @default.
• W3128782885 hasConcept C2778943923 @default.
• W3128782885 hasConcept C2779030066 @default.
• W3128782885 hasConcept C2911091166 @default.
• W3128782885 hasConcept C502942594 @default.
• W3128782885 hasConcept C54009773 @default.
• W3128782885 hasConcept C54355233 @default.
• W3128782885 hasConcept C71924100 @default.
• W3128782885 hasConcept C7876069 @default.
• W3128782885 hasConcept C81885089 @default.
• W3128782885 hasConcept C86803240 @default.
• W3128782885 hasConceptScore W3128782885C111335760 @default.
• W3128782885 hasConceptScore W3128782885C126322002 @default.
• W3128782885 hasConceptScore W3128782885C142724271 @default.
• W3128782885 hasConceptScore W3128782885C161997846 @default.
• W3128782885 hasConceptScore W3128782885C16930146 @default.
• W3128782885 hasConceptScore W3128782885C170493617 @default.
• W3128782885 hasConceptScore W3128782885C198826908 @default.
• W3128782885 hasConceptScore W3128782885C203014093 @default.
• W3128782885 hasConceptScore W3128782885C2778943923 @default.
• W3128782885 hasConceptScore W3128782885C2779030066 @default.
• W3128782885 hasConceptScore W3128782885C2911091166 @default.
• W3128782885 hasConceptScore W3128782885C502942594 @default.

• next